SANGRAIL Trademark

Trademark Overview

On Thursday, January 22, 2026, a trademark application was filed for SANGRAIL with the United States Patent and Trademark Office. The USPTO has given the SANGRAIL trademark a serial number of 99608993. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 22, 2026. This trademark is owned by Sangrail Biologics Inc.. The SANGRAIL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medical and scientific research in the field of gene therapy; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use. Research and development of pharmaceuticals using gene editing

Pharmaceutical preparations for treatment of rare genetic diseases; pharmaceutical preparations primarily comprising cells for treatment of rare diseases; pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases.
sangrail

General Information

Serial Number99608993
Word MarkSANGRAIL
Filing DateThursday, January 22, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, January 22, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical and scientific research in the field of gene therapy; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use. Research and development of pharmaceuticals using gene editing
Goods and ServicesPharmaceutical preparations for treatment of rare genetic diseases; pharmaceutical preparations primarily comprising cells for treatment of rare diseases; pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 22, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 22, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSangrail Biologics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19103

Trademark Events

Event DateEvent Description
Thursday, January 22, 2026NEW APPLICATION ENTERED
Thursday, January 22, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

sangrail gene preparations pharmaceutical treatment diseases therapy research medical rare genetic